Skip to main content
SpringerLink
Log in

Effective Risk Management is the Key to Maximising the Benefits of Self Medication

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table 1
Table 2

References

  1. Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self medication. Drug Safety 2001; 24 (14): 1027–37

    Article  PubMed  CAS  Google Scholar 

  2. Segall A. A community survey of self-medication activities. Med Care 1990; 28: 301–10

    Article  PubMed  CAS  Google Scholar 

  3. Wearn A, Gill P, Gray M, et al. Pharmacists’ views on deregulating emergency hormonal contraception. Pharm J 2001; 266: 89–92

    Google Scholar 

  4. Blenkinsopp A, Bradley C. Patients, society, and the increase in self-medication. BMJ 1996; 312: 629–32

    Article  PubMed  CAS  Google Scholar 

  5. Soller RW. OTCS 2000: achievements and challenges. Drug Info J 2000; 34: 693–701

    Article  Google Scholar 

  6. Powis MG, Rogers PJ, Wood SM. United Kingdom community pharmacists’ views on recent ‘POM’ to ‘P’ switched medicines. J Soc Admin Pharm 1996; 13: 188–97

    Google Scholar 

  7. Erwin J, Britten N, Jones, R. General practitioners’ views on over the counter sales by community pharmacists. BMJ 1996; 312: 617–8

    Article  PubMed  CAS  Google Scholar 

  8. Sihvo S, Hemminki E, Ahonen R. Physicians’ attitudes towards reclassifying drugs as over-the-counter. Med Care 1999; 37: 518–25

    Article  PubMed  CAS  Google Scholar 

  9. Tasch RF, Goeree R, Henke CJ, et al. Switching the histamine H2-receptor antagonist famotidine to nonprescription status in Canada. Pharmacoeconomics 1996; 9: 61–75

    Article  PubMed  CAS  Google Scholar 

  10. Stearns SC, Bernard SL, Fasick SB, et al. The economic implications of self-care: the effect of lifestyle, functional adaptations and medical self-care among a national sample of Medicare beneficiaries. Am J Public Health 2000; 90: 1608–12

    Article  PubMed  CAS  Google Scholar 

  11. Ferris DG, Dekle C, Kitaker MS. Women’s use of over-the-counter antifungal medications for gynaecological symptoms. J Fam Pract 1996; 42: 595–600

    PubMed  CAS  Google Scholar 

  12. Anderson M, Schou JS. Safety implications of over-the-counter availability of H2-antagonists. Drug Saf 1993; 8: 179–85

    Article  Google Scholar 

  13. Holt GA, Hall EL. The self-care movement. In: American Pharmaceutical Association/The National Professional Society of Pharmacists. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Society 1990: 1–10

    Google Scholar 

  14. Chrischilles EA, Lemke JH, Wallace RB. Prevalence and characteristics of multiple analgesic drug use in an elderly patient study group. J Am Geriatr Soc 1990; 38: 979–84

    PubMed  CAS  Google Scholar 

  15. Kogan MD, Pappas G, Yu SM, et al. Over-the-counter medication use among US preschool-age children. JAMA 1994; 272: 1025–30

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Effective Risk Management is the Key to Maximising the Benefits of Self Medication. Drugs Ther. Perspect 19, 22–25 (2003). https://doi.org/10.2165/00042310-200319020-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200319020-00008

Keywords

Search

Navigation